CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Open-market sale Director sold 10,000 shares at an average $170.81 ($1,708,088)
- 4 Shares withheld for taxes Director gave up 115 shares (to pay taxes)
- 4 Planned sale Director sold 467 shares at an average $162.26 ($75,775)
- 4 Shares withheld for taxes CLO & Secretary gave up 1,325 shares (to pay taxes)
- 4 Planned sale Director sold 467 shares at $131.88 ($61,586)
- 4 Planned sale Director sold 934 shares at $125.00 ($116,750)
- 4 Conversion 10% owner acquired 1,500,000 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition CLO & Secretary acquired 233 shares (other)
- 4 Other acquisition Chief Financial Officer acquired 224 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 233 shares (other)
- 3/A Insider 3/A
- 4 Open-market sale CLO & Secretary sold 500 shares at $114.08 ($57,042)
- 4 Open-market sale CLO & Secretary sold 500 shares at $114.54 ($57,271)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 188 shares (to pay taxes)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
- 4 Grant or award Director acquired 1,209 shares (grant or award)
Page 4 of 51 · 1,001 filings